Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07808905) titled 'Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia' on Sept. 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: ENCell
Condition:
Sarcopenia
Intervention:
Drug: EN001
Drug: EN001
Drug: EN001
Drug: EN001
Drug: EN001
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: March 1, 2027
Target Sample Size: 132
Countries of Recruitment:
South Korea
To know more, visit https://...